Cargando…

Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy

BACKGROUND: Oral complications may be observed during chemotherapy and are important side effects that may directly affect the anticancer treatment, even causing septicaemia in some cases. This research was done in order to evaluate changes in oral lesions during follow-up of children and adolescent...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger Velten, Deise, Zandonade, Eliana, Monteiro de Barros Miotto, Maria Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047274/
https://www.ncbi.nlm.nih.gov/pubmed/27716167
http://dx.doi.org/10.1186/s12903-016-0300-2
_version_ 1782457392502407168
author Berger Velten, Deise
Zandonade, Eliana
Monteiro de Barros Miotto, Maria Helena
author_facet Berger Velten, Deise
Zandonade, Eliana
Monteiro de Barros Miotto, Maria Helena
author_sort Berger Velten, Deise
collection PubMed
description BACKGROUND: Oral complications may be observed during chemotherapy and are important side effects that may directly affect the anticancer treatment, even causing septicaemia in some cases. This research was done in order to evaluate changes in oral lesions during follow-up of children and adolescents in chemotherapy at Hospital Estadual Infantil Nossa Senhora da Glória (HEINSG). METHODS: The study design was longitudinal, 45 patients were evaluated and monitored for 1 month after the initiation of chemotherapy. Twenty-eight patients were male and 17 female, ranging from 3 months to 18 years old. RESULTS: The results show an increase in the number of mucositis cases and a decrease in xerostomia cases after the initiation of treatment, and other oral lesions were also found in low numbers. CONCLUSIONS: It is possible to avoid oral complications by maintaining a good oral health, and reducing infectious outbreaks. It is also feasible to obtain an early diagnosis of, and treat these oral complications, preventing them from following a more severe clinical course that may negatively affect the individual’s treatment. This outcome requires the presence of a dental surgeon on the multidisciplinary cancer treatment team.
format Online
Article
Text
id pubmed-5047274
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50472742016-10-11 Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy Berger Velten, Deise Zandonade, Eliana Monteiro de Barros Miotto, Maria Helena BMC Oral Health Research Article BACKGROUND: Oral complications may be observed during chemotherapy and are important side effects that may directly affect the anticancer treatment, even causing septicaemia in some cases. This research was done in order to evaluate changes in oral lesions during follow-up of children and adolescents in chemotherapy at Hospital Estadual Infantil Nossa Senhora da Glória (HEINSG). METHODS: The study design was longitudinal, 45 patients were evaluated and monitored for 1 month after the initiation of chemotherapy. Twenty-eight patients were male and 17 female, ranging from 3 months to 18 years old. RESULTS: The results show an increase in the number of mucositis cases and a decrease in xerostomia cases after the initiation of treatment, and other oral lesions were also found in low numbers. CONCLUSIONS: It is possible to avoid oral complications by maintaining a good oral health, and reducing infectious outbreaks. It is also feasible to obtain an early diagnosis of, and treat these oral complications, preventing them from following a more severe clinical course that may negatively affect the individual’s treatment. This outcome requires the presence of a dental surgeon on the multidisciplinary cancer treatment team. BioMed Central 2016-10-03 /pmc/articles/PMC5047274/ /pubmed/27716167 http://dx.doi.org/10.1186/s12903-016-0300-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Berger Velten, Deise
Zandonade, Eliana
Monteiro de Barros Miotto, Maria Helena
Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
title Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
title_full Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
title_fullStr Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
title_full_unstemmed Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
title_short Prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
title_sort prevalence of oral manifestations in children and adolescents with cancer submitted to chemotherapy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5047274/
https://www.ncbi.nlm.nih.gov/pubmed/27716167
http://dx.doi.org/10.1186/s12903-016-0300-2
work_keys_str_mv AT bergerveltendeise prevalenceoforalmanifestationsinchildrenandadolescentswithcancersubmittedtochemotherapy
AT zandonadeeliana prevalenceoforalmanifestationsinchildrenandadolescentswithcancersubmittedtochemotherapy
AT monteirodebarrosmiottomariahelena prevalenceoforalmanifestationsinchildrenandadolescentswithcancersubmittedtochemotherapy